Sign In

John Hood

John Hood is a renowned figure in the biomedicine industry, having founded or co-founded companies like Endeavor Biomedicines, Neuronomix, Impact Biomedicines, and Samumed.

With a strong background in drug discovery, cell signaling, oncology, and biomarker development, John has made significant contributions through his work and research, evidenced by being an author on over 100 journal articles and an inventor on over 100 patents.

Currently, John Hood holds the position of Board Chairman at Endeavor Biomedicines and serves as the Founder of Neuronomix.

Prior to his current roles, he was the founder and CEO of Impact Biomedicines, a company that was acquired by Celgene in January 2018.

John is highly skilled in the growth and management of start-up companies, as well as delivering scientific and clinical presentations to audiences of varying expertise levels.

He pursued his education at Texas A&M University, where he completed a Doctor of Philosophy (Ph.D.) and a Bachelor's Degree.

In his capacity as the Founder and Executive Chairman at Endeavor Biomedicines, John Hood continues to leave a significant impact on the field of biomedicine.

John Hood
Add to my network

Location

San Diego, California, United States